The danger theory of immunity revisited

Matzinger, P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12, 991–1045 (1994).

Article  CAS  PubMed  Google Scholar 

Burnet, F. M. The immunological significance of the thymus: an extension of the clonal selection theory of immunity. Australas. Ann. Med. 11, 79–91 (1962).

Article  CAS  PubMed  Google Scholar 

Blackman, M., Kappler, J. & Marrack, P. The role of the T cell receptor in positive and negative selection of developing T cells. Science 248, 1335–1341 (1990).

Article  CAS  PubMed  Google Scholar 

Kroemer, G. & Martinez, C. The fail–safe paradigm of immunological self-tolerance. Lancet 338, 1246–1249 (1991).

Article  CAS  PubMed  Google Scholar 

Vance, R. E. Cutting edge: cutting edge commentary: a Copernican revolution? Doubts about the danger theory. J. Immunol. 165, 1725–1728 (2000).

Article  CAS  PubMed  Google Scholar 

Medzhitov, R. & Janeway, C. A. Jr. Decoding the patterns of self and nonself by the innate immune system. Science 296, 298–300 (2002).

Article  CAS  PubMed  Google Scholar 

Pradeu, T. & Cooper, E. L. The danger theory: 20 years later. Front. Immunol. 3, 287 (2012).

Article  PubMed  PubMed Central  Google Scholar 

Land, W. G. & Messmer, K. The danger theory in view of the injury hypothesis: 20 years later. Front. Immunol. 3, 349 (2012).

Article  PubMed  PubMed Central  Google Scholar 

Seong, S. Y. & Matzinger, P. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat. Rev. Immunol. 4, 469–478 (2004).

Article  CAS  PubMed  Google Scholar 

Matzinger, P. & Kamala, T. Tissue-based class control: the other side of tolerance. Nat. Rev. Immunol. 11, 221–230 (2011).

Article  CAS  PubMed  Google Scholar 

Matzinger, P. The danger model: a renewed sense of self. Science 296, 301–305 (2002).

Article  CAS  PubMed  Google Scholar 

Gong, T., Liu, L., Jiang, W. & Zhou, R. DAMP-sensing receptors in sterile inflammation and inflammatory diseases. Nat. Rev. Immunol. 20, 95–112 (2020).

Article  CAS  PubMed  Google Scholar 

Carroll, S. L., Pasare, C. & Barton, G. M. Control of adaptive immunity by pattern recognition receptors. Immunity 57, 632–648 (2024).

Article  CAS  PubMed  Google Scholar 

Ma, M., Jiang, W. & Zhou, R. DAMPs and DAMP-sensing receptors in inflammation and diseases. Immunity 57, 752–771 (2024).

Article  CAS  PubMed  Google Scholar 

Huang, Y., Jiang, W. & Zhou, R. DAMP sensing and sterile inflammation: intracellular, intercellular and inter-organ pathways. Nat. Rev. Immunol. 24, 703–719 (2024).

Article  CAS  PubMed  Google Scholar 

Lee, M. H. et al. How bile acids and the microbiota interact to shape host immunity. Nat. Rev. Immunol. https://doi.org/10.1038/s41577-024-01057-x (2024).

Remick, B. C., Gaidt, M. M. & Vance, R. E. Effector-triggered immunity. Annu. Rev. Immunol. 41, 453–481 (2023).

Article  CAS  PubMed  Google Scholar 

Ma, Y. & Kroemer, G. The cancer-immune dialogue in the context of stress. Nat. Rev. Immunol. 24, 264–281 (2024).

Article  CAS  PubMed  Google Scholar 

Tuzlak, S. et al. Repositioning TH cell polarization from single cytokines to complex help. Nat. Immunol. 22, 1210–1217 (2021).

Article  CAS  PubMed  Google Scholar 

Ginhoux, F., Guilliams, M. & Merad, M. Expanding dendritic cell nomenclature in the single-cell era. Nat. Rev. Immunol. 22, 67–68 (2022).

Article  CAS  PubMed  Google Scholar 

Lazarov, T., Juarez-Carreno, S., Cox, N. & Geissmann, F. Physiology and diseases of tissue-resident macrophages. Nature 618, 698–707 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kroemer, G., Chan, T. A., Eggermont, A. M. M. & Galluzzi, L. Immunosurveillance in clinical cancer management. CA Cancer J. Clin. 74, 187–202 (2024).

Article  PubMed  Google Scholar 

Rood, J. E. & Behrens, E. M. Inherited autoinflammatory syndromes. Annu. Rev. Pathol. 17, 227–249 (2022).

Article  CAS  PubMed  Google Scholar 

Bousfiha, A. et al. The 2022 update of IUIS phenotypical classification for human inborn errors of immunity. J. Clin. Immunol. 42, 1508–1520 (2022).

Article  PubMed  Google Scholar 

Akalu, Y. T. & Bogunovic, D. Inborn errors of immunity: an expanding universe of disease and genetic architecture. Nat. Rev. Genet. 25, 184–195 (2024).

Article  CAS  PubMed  Google Scholar 

Kepp, O., Marabelle, A., Zitvogel, L. & Kroemer, G. Oncolysis without viruses — inducing systemic anticancer immune responses with local therapies. Nat. Rev. Clin. Oncol. 17, 49–64 (2020).

Article  CAS  PubMed  Google Scholar 

Liu, J. et al. Improved efficacy of neoadjuvant compared to adjuvant immunotherapy to eradicate metastatic disease. Cancer Discov. 6, 1382–1399 (2016).

Article  CAS  PubMed  Google Scholar 

Blank, C. U. et al. Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma. Nat. Med. 24, 1655–1661 (2018).

Article  CAS  PubMed  Google Scholar 

Patel, S. P. et al. Neoadjuvant-adjuvant or adjuvant-only pembrolizumab in advanced melanoma. N. Engl. J. Med. 388, 813–823 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Galluzzi, L., Yamazaki, T. & Kroemer, G. Linking cellular stress responses to systemic homeostasis. Nat. Rev. Mol. Cell Biol. 19, 731–745 (2018).

Article  CAS  PubMed  Google Scholar 

Yuan, J. & Ofengeim, D. A guide to cell death pathways. Nat. Rev. Mol. Cell Biol. 25, 379–395 (2024).

Article  CAS  PubMed  Google Scholar 

Medzhitov, R. & Iwasaki, A. Exploring new perspectives in immunology. Cell 187, 2079–2094 (2024).

Article  CAS  PubMed  Google Scholar 

Caron, E. et al. The MHC I immunopeptidome conveys to the cell surface an integrative view of cellular regulation. Mol. Syst. Biol. 7, 533 (2011).

Article  PubMed  PubMed Central  Google Scholar 

Comments (0)

No login
gif